Store

https://intelliquit-consumer.myshopify.com/collections/all-products

ABOUT US

The mission of IntelliQuit™ is using state of the art technology to eliminate the morbidity and mortality caused by the global tobacco pandemic, increasing value for our customers and clinical partners. Offering a suite of tobacco treatment products and services, our first product and service to market is the world’s first cloud-based nicotine monitoring platform.

Team IntelliQuit consists of a CEO who has been a thought leader in tobacco treatment for over 3 decades. Since September 11, 2001 he has been the Director of Tobacco Treatment for the Fire Department of the City of New York (FDNY) and may have treated more tobacco dependent individuals than anyone else in the United States. Since September 2001, FDNY tobacco prevalence has been reduced from 28% to less than 4 percent, with a biochemically confirmed quit rate of ~70% at 10-year follow-up. Our CEO is also on the editorial boards of the Journal of Smoking Cessation and the Journal of Medical Internet Research. Our Medical Director is a board-certified pulmonologist and critical care specialist with extensive experience treating the tobacco dependent. Our team also includes experts in computer vision, neural network architecture, mobile app development, marketing and business operations.

Quick links

Home
About us
Medical library
Legal

Newsletter

Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device

choosing a selection results in a full page refresh
press the space key then arrow keys to make a selection